A medical device recall lawsuit is a legal claim brought by patients or their families against manufacturers of medical devices that fail to perform safely or as intended, causing injury or death. These lawsuits typically arise after the FDA issues a recall—either voluntary or mandatory—identifying a defect in the device that poses a serious risk to patient health. When a company distributes a faulty insulin pump that delivers incorrect doses, a glucose monitor that fails to alert users to dangerous blood sugar drops, or an implant that degrades prematurely in the body, patients harmed by these failures have the right to seek compensation for medical expenses, lost wages, pain and suffering, and other damages. The medical device industry is highly regulated, yet recalls remain common, with the FDA overseeing approximately 900 device recalls annually. In recent years, medical device recalls have affected hundreds of thousands of patients. The FDA reported 3,934 total device recalls between 2020 and 2024, all of which were voluntary manufacturer-initiated withdrawals. Some of the most serious recent cases involve insulin pumps and continuous glucose monitors used by diabetic patients.
For example, in March 2026, the FDA issued a Class I recall of OmniPod 5 insulin pumps due to internal tubing defects that could cause under-delivery of insulin, potentially leading to life-threatening diabetic ketoacidosis. Similarly, Abbott’s FreeStyle Libre 3 glucose sensors were recalled in February 2026 after documented cases of the sensor delivering incorrect low glucose readings, with 860 serious injuries reported globally. These recalls underscore a critical reality: even FDA-approved medical devices can fail with dangerous consequences. Medical device recall lawsuits serve an important function beyond compensating victims. They hold manufacturers accountable for design flaws, manufacturing defects, and failure to warn about known risks. Settlement amounts vary widely depending on the severity of injuries sustained, ranging from $150,000 for minor injuries to over $3 million in cases involving death or permanent disability. Understanding your rights if you’ve been harmed by a recalled medical device is essential, as there are typically strict deadlines and specific procedures for filing claims.
Table of Contents
- How Does a Medical Device Recall Happen and What Triggers a Lawsuit?
- Why Are Serious Recalls Surprisingly Rare Despite Thousands of Recalls Annually?
- What Types of Defects Cause the Most Dangerous Recalls?
- How Do Medical Device Recall Settlements Get Determined?
- What Are the Emerging Risks With AI-Enabled Medical Devices?
- What Should You Do If You Have Been Harmed by a Recalled Medical Device?
- The Future of Medical Device Accountability
- Conclusion
How Does a Medical Device Recall Happen and What Triggers a Lawsuit?
The FDA’s medical device recall process begins when a manufacturer discovers or learns of a problem with a device—either through adverse event reports, customer complaints, or internal testing. Manufacturers are required to report adverse events to the FDA through the MedWatch system. When a defect is confirmed, the manufacturer typically issues a voluntary recall, removing the product from the market or issuing warnings to healthcare providers and patients. The FDA classifies recalls by severity: Class I recalls involve serious injury or death risk, Class II recalls involve potential but less serious adverse health effects, and Class III recalls involve minor health effects unlikely to cause serious adverse reactions. A medical device recall lawsuit typically follows once patients have been harmed and the defect is documented. Injured patients or their families file claims either individually or as part of a class action lawsuit, where multiple victims with similar injuries join together to pursue compensation. The Dexcom G6 and G7 continuous glucose monitor case illustrates this pattern: after the devices’ speaker malfunction caused users to miss critical blood sugar alerts, leading to dozens of severe injuries, Wisner Baum filed a class action lawsuit in September 2025 in U.S.
District Court for the Southern District of California. In that case, the defect—speakers that failed to deliver audible alerts—directly caused preventable harm to diabetic patients who relied on the devices for life-saving information. Some of the largest recalls have affected hundreds of thousands of patients at once. Medtronic’s recall of more than 500,000 MiniMed insulin pumps due to a design flaw causing devices to deliver too much or too little insulin demonstrates the scale of potential exposure. When a single defect affects that many devices, the number of injured patients and resulting lawsuits can be substantial. However, not all recalled devices harm patients equally—some recalls are issued out of extreme caution even when few actual injuries have occurred. This is why individual injury severity plays such a large role in determining lawsuit outcomes.
Why Are Serious Recalls Surprisingly Rare Despite Thousands of Recalls Annually?
While the FDA oversees roughly 900 device recalls per year, a striking fact emerges from the data: the FDA has issued zero mandatory recalls in the past five years (2020-2024). All 3,934 recalls during this period were voluntarily withdrawn by manufacturers themselves. This might seem surprising given the number of recalls, but it reflects how the recall system is designed. The FDA’s primary enforcement tool is to request that manufacturers recall products, and manufacturers nearly always comply without needing FDA to exercise its mandatory recall authority. Since 1990, the FDA has used its mandatory recall power only four times in 36 years, reserving this extreme measure for the most egregious cases where a manufacturer refuses to act. This reliance on voluntary recalls creates an important limitation in the system. Manufacturers have financial incentives to delay announcing recalls or to classify them at lower severity levels than warranted.
For example, a company might classify a recall as Class II (unlikely to cause serious harm) when evidence suggests Class I (serious risk of injury or death) would be more appropriate. Patients and healthcare providers depend on accurate classification to understand the urgency of removing a device from use. Additionally, the voluntary nature of recalls means that some devices may remain in patients’ bodies or in clinical use longer than necessary while a manufacturer decides how to respond. The Exactech knee replacement implant situation demonstrates this complexity: the polyethylene inserts in these implants, manufactured after 2004, degrade over time inside patients’ bodies, forcing revision surgeries. The litigation has generated 132 pending cases in multidistrict litigation (MDL), yet patients may have had the defective devices implanted years before the recall was initiated. Another limitation of the current system is the gap between when the FDA discovers a potential problem and when manufacturers take action. Adverse event reports submitted to MedWatch can take months or years to accumulate enough evidence to warrant action, during which more patients may be harmed. Furthermore, some manufacturers operate internationally, and a recall in one country may not automatically trigger recalls in others, creating situations where patients in certain regions continue using recalled devices longer than those elsewhere.
What Types of Defects Cause the Most Dangerous Recalls?
Medical device defects fall into several categories, each posing different risks. Design defects involve flawed engineering where the device concept itself is unsafe—like the OmniPod 5’s internal tubing that tears and causes insulin under-delivery. Manufacturing defects occur when devices are produced incorrectly despite a sound design—such as improper assembly causing components to fail. Failure-to-warn defects happen when manufacturers know or should know of risks but fail to adequately alert doctors and patients. Abbott’s FreeStyle Libre 3 recall involved multiple elements: the sensor’s glucose readings were inaccurate, delivering incorrect low glucose readings that could cause patients to miss dangerous blood sugar episodes or over-treat them with insulin. Defects in devices that deliver medication—insulin pumps, infusion pumps, and drug-delivery systems—pose particularly acute risks because they directly control dosing. When these devices malfunction, patients receive either insufficient or excessive medication.
Insulin delivered inconsistently can cause hypoglycemia (dangerously low blood sugar) or hyperglycemia (dangerously high blood sugar), both of which can be life-threatening. The Medtronic MiniMed recall of over 500,000 units exemplifies this danger: a design flaw caused inconsistent insulin delivery, putting patients at risk for both hypo- and hyperglycemic reactions. These cases typically result in higher settlement amounts because the harm is severe and directly linked to the device failure. Implantable devices like the Exactech knee replacement implants present a different challenge. These devices fail slowly inside patients’ bodies, degrading over time. Patients may not realize the device is failing until they experience increased pain, reduced mobility, or swelling. At that point, revision surgery becomes necessary—a painful, expensive, and sometimes risky procedure. The fact that 132 cases have reached MDL status in the Exactech litigation reflects not just the number of affected patients but the complexity of proving that device degradation caused specific injuries requiring surgical intervention.
How Do Medical Device Recall Settlements Get Determined?
Settlement amounts in medical device recall cases vary dramatically based on several factors: the severity of the injury sustained, whether permanent disability resulted, age and life expectancy of the plaintiff, medical expenses incurred, lost income, and the strength of evidence linking the device defect directly to the harm. General settlement ranges reported for medical device recalls span from $150,000 for minor injuries to $3 million or more for cases involving death or permanent disability. However, these figures are broad generalizations, and actual settlements depend heavily on case-specific circumstances. The process of determining settlement value typically involves negotiation between plaintiffs’ attorneys and defendants’ insurance counsel. In class action cases like the Dexcom lawsuit, attorneys must propose a settlement structure that fairly compensates all class members—those with severe injuries typically receive more than those with minor complications.
For individual lawsuits, settlement discussions often hinge on medical records documenting the injury, expert testimony linking the device defect to the harm, and evidence of economic damages like hospital bills and rehabilitation costs. A patient whose Dexcom speaker malfunction caused a severe hypoglycemic episode resulting in hospitalization and permanent cognitive damage would logically receive a much larger settlement than a patient who experienced a missed alert but suffered no lasting harm. An important limitation to understand is that settlement negotiations often favor cases with clear causation and significant medical expenses. Cases involving devices implanted years ago, like the Exactech knee replacements, sometimes face challenges proving that device degradation—rather than normal wear and tear or the patient’s age—caused the need for revision surgery. Additionally, settlement funds are finite: in large MDL cases with hundreds or thousands of claimants, the total settlement pool is divided among all qualifying claimants, so individual payments may be reduced if far more people claim injuries than initially anticipated.
What Are the Emerging Risks With AI-Enabled Medical Devices?
A new and concerning trend involves recalls of artificial intelligence-enabled medical devices. Between 2024 and 2025, the FDA has recalled more than 60 AI-enabled devices, including infusion systems that deliver inaccurate medication doses and imaging software that mislabels healthy organs as diseased. These recalls highlight a gap in the regulatory framework: AI systems can behave differently than their developers anticipated, especially when confronted with unusual patient presentations or data variations the AI was not trained to recognize. When an infusion pump’s AI system miscalculates a medication dose, the consequences can be immediate and severe. When imaging software misidentifies a healthy organ as diseased, patients may undergo unnecessary surgeries with their own serious risks. The challenge with AI device recalls is that manufacturers and the FDA sometimes struggle to explain exactly why the AI failed.
Traditional device recalls can often be traced to a specific component failure or design flaw. With AI systems, the failure may emerge from the algorithm’s training data, the environment where it’s deployed, or unexpected interactions with other systems. This opacity can make it harder for patients to understand their risk and easier for manufacturers to downplay the significance of the problem. Furthermore, AI devices can be updated remotely via software patches, which raises questions about whether a “fix” truly resolves the underlying problem or merely changes its manifestation. A warning for patients using AI-enabled devices: stay informed about manufacturer updates and FDA alerts specific to your device, and don’t assume a software patch completely eliminates the risk that prompted the recall. The growth of AI in medical devices is inevitable and potentially beneficial, but it underscores why robust regulation and transparent communication about device limitations remain critical. As more complex AI-enabled devices enter the market, medical device recall lawsuits will likely become more common and more technically complicated to litigate, potentially increasing legal costs and settlement timelines.
What Should You Do If You Have Been Harmed by a Recalled Medical Device?
If you believe you’ve been injured by a recalled medical device, the first step is to document everything: gather all medical records related to your injury, save the device itself or its packaging (which contains the model and serial number), and note the dates when you used the device and when you experienced harm. Report the adverse event to the FDA’s MedWatch program yourself if the manufacturer has not done so—this creates an official record of your injury. Consult with an attorney experienced in medical device liability to evaluate whether you have a valid claim and whether joining a class action lawsuit or filing an individual suit makes more sense for your situation.
Timing is critical because most medical device lawsuits are subject to statutes of limitations, which vary by state but typically range from two to three years from the time you discovered the injury or should have discovered it. Some lawsuits include a claims administration process where you submit documentation of your injury to a neutral claims administrator who determines your eligibility and settlement amount based on predetermined criteria. The key is not to delay: waiting too long can result in losing your right to sue entirely, while filing promptly preserves your legal options.
The Future of Medical Device Accountability
As medical devices become more sophisticated and integrated into patient care, the question of accountability remains unresolved. The FDA’s 36-year track record of using mandatory recall authority only four times suggests the agency relies heavily on manufacturer cooperation rather than enforcement. This approach works when manufacturers act responsibly, but it creates risk when companies prioritize profits over safety. Legislative proposals to strengthen FDA enforcement powers and increase penalties for dangerous device recalls periodically emerge, though lasting change has been limited.
Patients harmed by recalled devices will continue to pursue lawsuits as a mechanism to hold manufacturers accountable and obtain compensation—a necessity when the regulatory system alone proves insufficient. The medical device industry’s size and economic importance mean that significant change in regulation or enforcement will likely be gradual. However, high-profile recalls like OmniPod 5, Abbott FreeStyle Libre 3, and the Exactech implant cases keep public and legislative attention focused on the problem. As AI-enabled devices multiply and the complexity of medical device technology increases, the importance of a robust legal system to compensate injured patients becomes more, not less, critical.
Conclusion
Medical device recall lawsuits represent a critical avenue for patients harmed by dangerous or defective devices to obtain compensation and hold manufacturers accountable. The FDA oversees approximately 900 device recalls annually, and between 2020 and 2024, 3,934 devices were recalled—all voluntarily by manufacturers. Despite this large number, some of the most serious defects have caused substantial harm: insulin pumps delivering incorrect doses, glucose monitors failing to alert users to dangerous blood sugar levels, and implants degrading inside patients’ bodies. Settlement amounts range widely from $150,000 for minor injuries to $3 million or more for death or permanent disability, depending on injury severity and the strength of evidence linking the device to the harm.
If you have been injured by a recalled medical device, understanding your legal rights is essential. Document your injury thoroughly, report the adverse event to the FDA, and consult with an experienced medical device liability attorney. The statute of limitations for filing a lawsuit typically ranges from two to three years from discovery of the injury, so acting promptly is important. Medical device recall lawsuits not only provide compensation to injured patients but also serve as an important mechanism to incentivize manufacturers to prioritize safety in design, manufacturing, and post-market monitoring.